UF Innovate | Accelerate Earns Four Honors at InBIA ICBI Conference Awards Ceremony (Global Innovation Institute)
The UF Innovate | Accelerate program was recognized at the InBIA International Business Innovation Association ICBI Conference Awards Ceremony, earning four major honors.
Is Space Biotech Building Its Apps Before Its Operating System? (Hyper Frame)
UF Innovate | Accelerate resident client Aloft Biotechnologies is developing a novel microgravity bioreactor using air-film technology to enable scalable cell culture, highlighting the critical role of hardware innovation in the future of orbital biotechnology.
Synvitta Diagnostics Announces Bold Mission To Advance Multiplex Diagnostic Testing (Alachua Chronicle)
UF Innovate | Accelerate resident client Synvitta Diagnostics, Inc., a biotechnology company developing next-generation diagnostic solutions, announced a strategic partnership between Mitch Glaeser, Co-Founder and Chief Executive Officer, and Rainara Almeida, M.Sc., Co-Founder and Chief Scientific Officer.
Pheronym Awarded $378,000 NSF Phase IIB Supplemental Funding To Accelerate Commercialization and Scale Manufacturing (EIN Presswire)
UF Innovate | Accelerate alum Pheronym, an ag-biotech pest control company, announced it has been awarded $378,000 in National Science Foundation (NSF) SBIR Phase IIB supplemental funding.
Inside LPRC IMPACT 2026
A cool opening-night reception at UF Innovate | The Hub and the LPRC INNOVATE labs marked the start of a learning-packed few days at the 2026 LPRC IMPACT Conference, March 17-19.
Oragenics Receives HREC Approval for Phase IIa Clinical Trial of ONP-002 as a Treatment for Concussion and Mild Traumatic Brain Injury in Australia (Globe Newswire)
UF Innovate | Accelerate graduate Oragenics has received final ethics approval in Australia to begin its Phase IIa clinical trial of ONP-002, an intranasal therapy being developed to treat concussion and mild traumatic brain injury.
Verizon Is Investing in a New Generation of Life-Saving Disaster Resilience Technology (Verizon)
UF Innovate | Accelerate resident client FNN has been selected as one of four innovators in the 2025 Verizon Disaster Resilience Prize, a $1 million program supporting technologies that help communities better prepare for and respond to natural disasters.
Oragenics Targets Projected $9 Billion Market by Advancing First and Only Clinical-Stage Concussion and Mild Traumatic Brain Injury Therapy (Globe Newswire)
UF Innovate | Accelerate graduate Oragenics, Inc. outlined its 2026 milestones as it advances ONP-002, a novel intranasal neurosteroid in clinical development for concussion and mild traumatic brain injury.
Solid Biosciences Announces Positive Feedback From Type C Meeting With FDA for SGT-003 Gene Therapy for Duchenne Muscular Dystrophy (Globe Newswire)
Solid Biosciences Inc., which acquired UF startup AavantiBio, announced a positive regulatory update from its recent Type C meeting with the U.S. FDA that supports the continued advancement of SGT-003 as a potential treatment for Duchenne muscular dystrophy.
Oragenics Partners With DUCK FLATS Pharma To Support FDA IND Readiness and Clinical Trial Design for Concussion Program (Globe Newswire)
UF Innovate | Accelerate graduate Oragenics announced it has engaged DUCK FLATS Pharma as its U.S. Investigational New Drug (IND) readiness and regulatory execution partner to support FDA-facing preparation and clinical trial design as the Company advances its novel intranasal concussion therapy toward U.S.-based development.